المؤلفون: T. A. Kuropatkina, K. F. Gufranov, F. Yu. Sychev, M. M. Artemieva, G. N. Bondarenko, D. I. Esaulenko, T. V. Samoylenko, V. V. Shyshkina, N. A. Medvedeva, O. S. Medvedev, Т. А. Куропаткина, Х. Ф. Гуфранов, Ф. Ю. Сычев, М. М. Артемьева, Г. Н. Бондаренко, Д. И. Есауленко, Т. В. Самойленко, В. В. Шишкина, Н. А. Медведева, О. С. Медведев

المساهمون: The study was carried out within the framework of a scientific project of the state assignment of the Government of the Russian Federation to the Federal State Budget Educational Institution of Higher Education M.V.Lomonosov Moscow State University, The Government of the Russian Federation No.121032300071-8, Исследование выполнено в рамках научного проекта государственного задания Правительства Российской Федерации Федеральному государственному бюджетному образовательному учреждению высшего образования «Московский государственный университет имени М.В.Ломоносова» Правительства Российской Федерации № 121032300071-8

المصدر: PULMONOLOGIYA; Том 34, № 1 (2024); 19-30 ; Пульмонология; Том 34, № 1 (2024); 19-30 ; 2541-9617 ; 0869-0189

مصطلحات موضوعية: крысы. Конфликт интересов. Конфликт интересов авторами не заявлен, inhalation, monocrotaline form of pulmonary hypertension, interstitial lung disease, mast cells, tryptase, fibrosis, TGF-β, rats, ингаляции, монокроталиновая форма легочной гипертензии, интерстициальная болезнь легких, тучные клетки, триптаза, фиброз

وصف الملف: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/4485/3596; Poch D., Mandel J. Pulmonary hypertension. Ann. Intern. Med. 2021; 174 (4): ITC49–64. DOI:10.7326/AITC202104200.; Simonneau G., Gatzoulis M., Adatia I. et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62 (25, Suppl.): D34–41. DOI:10.1016/j.jacc.2013.10.029.; Waxman A., Elia D., Adir Y. et al. Recent advances in the management of pulmonary hypertension with interstitial lung disease. Eur. Respir. Rev. 2022; 31 (165): 210220. DOI:10.1183/16000617.0220-2021.; Nogueira-Ferreira R., Vitorino R., Ferreira R., Henriques-Coelho T. Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach. Pulm. Pharmacol. Ther. 2015; 35: 8–16. DOI:10.1016/j.pupt.2015.09.007.; Cui Y., Robertsonb J., Maharaj S. et al. Oxidative stress contributes to the induction and persistence of TGF-β1 induced pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2011; 43 (8): 1122–1133. DOI:10.1016/j.biocel.2011.04.005.; Ohsawa I., Ishikawa M., Takahashi K. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 2007; 13 (6): 688–694. DOI:10.1038/nm1577.; Iida A., Nosaka N., Yumoto T. et al. The clinical application of hydrogen as a medical treatment. Acta Med. Okayama. 2016; 70 (5): 331–337. DOI:10.18926/amo/54590.; Liu C., Zhang K., Chen G. Hydrogen therapy: from mechanism to cerebral diseases. Med. Gas Res. 2016; 6 (1): 48–54. DOI:10.4103/2045-9912.179346.; Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol. Ther. 2014; 144 (1): 1–11. DOI:10.1016/j.pharmthera.2014.04.006.; Ge L., Yang M., Yang N. et al. Molecular hydrogen: a preventive and therapeutic medical gas for various diseases. Oncotarget. 2017; 8 (60): 102653–102673. DOI:10.18632/oncotarget.21130.; Huang L. Molecular hydrogen: a therapeutic antioxidant and beyond. Med. Gas. Res. 2016; 6 (4): 219–222. DOI:10.4103/2045-9912.196904.; Шогенова Л.В., Туе Т.Ч., Крюкова Н.О. и др. Ингаляционный водород в реабилитационной программе медицинских работников, перенесших COVID-19. Кардиоваскулярная терапия и профилактика. 2021; 20 (6): 2986. DOI:10.15829/1728-8800-2021-2986.; Nicolson G., de Mattos G., Settineri R. et al. Clinical effects of hydrogen administration: from animal and human diseases to exercise medicine. Int. J. Clin. Med. 2016; 7 (1): 32–76. DOI:10.4236/ijcm.2016.71005.; Liu L., Shi Q., Liu X. et al. Attenuation of myocardial fibrosis using molecular hydrogen by inhibiting the TGF-β signaling pathway in spontaneous hypertensive rats. Am. J. Hypertension. 2022; 35 (2): 156–163. DOI:10.1093/ajh/hpab159.; Nakayama M., Itami N., Suzuki H. et al. Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: a prospective observational study. Sci. Rep. 2018; 8 (1): 254. DOI:10.1038/s41598-017-18537-x.; Kishimoto Y., Kato T., Ito M. et al. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects. J. Thorac. Cardiovasc. Surg. 2015; 150 (3): 645–654. DOI:10.1016/j.jtcvs.2015.05.052.; Wang Y., Jing L., Zhao X.M. et al. Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model. Respir. Res. 2011; 12 (1): 26. DOI:10.1186/1465-9921-12-26.; He B., Zhang Y., Kang B. et al. Protection of oral hydrogen water as an antioxidant on pulmonary hypertension. Mol. Biol. Rep. 2013; 40 (9): 5513–5521. DOI:10.1007/s11033-013-2653-9.; Sano M., Ichihara G., Katsumata Y. et al. Pharmacokinetics of a single inhalation of hydrogen gas in pigs. PLoS One. 2020; 15 (6): e0234626. DOI:10.1371/journal.pone.0234626.; Ichihara G., Katsumata Y., Moriyama H. et al. Pharmacokinetics of hydrogen after ingesting a hydrogen-rich solution: a study in pigs. Heliyon. 2021; 7 (11): e08359. DOI:10.1016/j.heliyon.2021.e08359.; Wijsenbeek M., Suzuki A., Maher T. Interstitial lung diseases. Lancet. 2022; 400 (10354): 769–786. DOI:10.1016/S0140-6736(22)01052-2.; Kuropatkina T., Pavlova O., Gulyaev M. et al. Sex-dependent protective effect of combined application of solubilized ubiquinol and Selenium on monocrotaline-induced pulmonary hypertension in Wistar rats. Antioxidants (Basel). 2022; 11 (3): 1–16. DOI:10.3390/antiox11030549.; Otoupalova E., Smith S., Cheng G., Thannickal V.J. Oxidative stress in pulmonary fibrosis. Compr. Physiol. 2020; 10 (2): 509–547. DOI:10.1002/cphy.c190017.; Ohta S. Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic application. Curr. Pharm. Des. 2011; 17 (22): 2241–2252. DOI:10.2174/138161211797052664.; Komi D., Mortaz E., Amani S. et al. The role of mast cells in IgE-Independent lung diseases. Clin. Rev. Allergy Immunol. 2020; 58 (3): 377–387. DOI:10.1007/s12016-020-08779-5.; Atiakshin D., Kostin A., Volodkin A. et al. Mast cells as a potential target of molecular hydrogen in regulating the local tissue microenvironment. Pharmaceuticals (Basel). 2023; 16 (6): 817. DOI:10.3390/ph16060817.; Shi J., Duncan B., Kuang X. Hydrogen treatment: a novel option in liver diseases. Clin. Med. (Lond.). 2021; 21 (2): e223–227. DOI:10.7861/clinmed.2020-0370.; Farha S., Sharp J., Asosingh K. et al. Mast cell number, phenotype, and function in human pulmonary arterial hypertension. Pulm. Circ. 2012; 2 (2): 220–228. DOI:10.4103/2045-8932.97609.; Tsang Y., Panjabi S., Funtanilla V. et al. Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD). Pulm. Circ. 2023; 13 (2): e12218. DOI:10.1002/pul2.12218.; Liu H., Liang X., Wang D. et al. Combination therapy with nitric oxide and molecular hydrogen in a murine model of acute lung injury. Shock. 2015; 43 (5): 504–511. DOI:10.1097/shk.0000000000000316.; https://journal.pulmonology.ru/pulm/article/view/4485

الاتاحة: https://journal.pulmonology.ru/pulm/article/view/4485
https://doi.org/10.18093/0869-0189-2024-34-1-19-30

المؤلفون: T. A. Poliakova, A. V. Shatokhina, G. N. Bondarenko, D. V. Politov, Т. А. Полякова, А. В. Шатохина, Г. Н. Бондаренко, Д. В. Политов

المصدر: Vavilov Journal of Genetics and Breeding; Том 22, № 6 (2018); 654-659 ; Вавиловский журнал генетики и селекции; Том 22, № 6 (2018); 654-659 ; 2500-3259 ; 2500-0462

مصطلحات موضوعية: популяционная структура, Spiraea f lexuosa, Spiraea chamaedryfolia, nuclear microsatellite loci, SSR, multiplex panels, genetic variability, population structure, ядерные микросателлитные локусы, мультиплексные панели, генетическая изменчивость

وصف الملف: application/pdf

Relation: https://vavilov.elpub.ru/jour/article/view/1649/1114; Ashizawa K., Kimura M.K., Takahashi A., Lian Ch., Kuramoto N. Development of microsatellite markers in a riparian shrub, Spiraea thunbergii (Rosaceae). Am. J. Bot. 2012;99(7):e283­e285. DOI 10.3732/ajb.1100587.; Brzyski J.R. Isolation and characterization of microsatellite markers in the rare clonal plant, Spiraea virginiana (Rosaceae). Am. J. Bot. 2010;97:e20­e22. DOI 10.3732/ajb.1000008.; Doyle J.J., Doyle J.L. Isolation of plant DNA from fresh tissue. Focus. 1990;12:12­15. Earl D.A., von Holdt B.M. STRUCTURE HARVESTER: a website and program for visualizing STRUCTURE output and implementing the Evanno method. Conserv. Genet. Resour. 2012;4:359­361. DOI 10.1007/s12686­011­9548­7.; Evanno G., Regnaut S., Goudet J. Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study. Mol. Ecol. 2005;14:2611­2620. DOI 10.1111/j.1365­294X.2005.02553.x.; Huh M.K. Genetic diversity and population structure of Spiraea prunifolia for. simpliciflora by inter­simple sequence repeats. J. Life Sci. 2009;19,9:1183­1189.; Jakobsson M., Rosenberg N.A. CLUMPP: a cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure. Bioinformatics. 2007;23(14): 1801­1806. DOI 10.1093/bioinformatics/btm233.; Khan G., Zhang F., Gao Q., Jiao X., Fu P., Xing R., Zhang J., Chen S. Isolation of 16 microsatellite markers for Spiraea alpina and S. mongolica (Rosaceae) of the Qinghai­Tibet Plateau. Appl. Plant Sci. 2014;2(1):e1­e4. DOI 10.3732/apps.1300059.; Peakall R., Smouse P.E. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research­an update. Bioinformatics. 2012;28:2537­2539. http://bioinformatics.oxfordjournals.org/content/28/19/2537.; Pojarkova A.I. Spiraeoideae Agardh. Flora of SSSR. Ed. V.L. Komarov. Moscow; Saint­Petersburg: Academy of Sciences of USSR Publ. 1939;9:279­318.; Polyakova T.A. Vnutrividovaya izmenchivost’ dal’nevostochnyh i sibirskih vidov roda Spiraea L. Novosibirsk, 2004. (in Russian); Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155:945­959.; Rosenberg N.A. DISTRUCT: a program for the graphical display of population structure. Publishers of Center for Computational Medicine and Biology. Department of Human Genetics. University of Michigan, 2007. http://rosenberglab.bioinformatics.med.umich.edu/distruct.html.; Van Oosterhout C., Hutchinson W.F., Wills D.P.M., Shipley P. Microchecker: software for identifying and correcting genotyping errors in microsatellite data. Mol. Ecol. Notes. 2004;4:535­538. DOI 10.1111/j.1471­8286.2004.00684.x.; Yeh F.C., Yang R.C., Boyle T. POPGENE Version 1.31. Microsoft Window­based freeware for population genetic analysis. 1999; available at http://www.ualberta.ca/~fyeh/index.htm.; Zhang F.­Q., Gao Q.­B., Zhang D.­J., Duan Y.­Z., Li Y.­H., Fu P.­ C., Xing R., Gulzar K., Chen S.­L. Phylogeography of Spiraea alpina in the Qinghai­Tibetan Plateau inferred from chloroplast DNA sequence variations. J. Syst. Evol. 2012;50(4):276­283. DOI 10.1111/j.1759­6831.2012.00194.x.; https://vavilov.elpub.ru/jour/article/view/1649

الاتاحة: https://vavilov.elpub.ru/jour/article/view/1649
https://doi.org/10.18699/VJ18.407